Across its top 20 institutional holders, ACET's holder base skews toward low-concentration, high-turnover investors on average (avg. concentration score 18/100, avg. turnover score 50/100).

Quarterly Activity

Recent Activity

+$15.2M

Total Buy Value

$16.1M

Total Sell Value

New buy9

Trim8

Add12

Sold out11

Net Buyers

Net Sellers

Smart Money Convergence

ACET does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/ACET

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

007002207

FAQ

Who are the top institutional investors holding ADICET BIO INC (ACET)?

Major stakeholders currently include Ra Capital Management, L.p. ($8.1M), Orbimed Advisors LLC ($7.0M), Franklin Resources INC ($4.3M). Based on the latest 13F filings, there are a total of 48 tracked investment funds and institutions maintaining positions in ACET.

What is the overall institutional sentiment toward ACET recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $12.5M, driven by 21 managers accumulating shares while 19 reduced their exposure.

Which institutions have been selling or reducing their ACET positions?

In the latest period, 8 funds trimmed their holdings, and 11 managers completely exited their positions. The aggregate reported sell value was $16.1M.

Are there any notable investors adding ACET to their portfolios?

Yes, buying activity remains notable. 9 institutions opened new positions in {ticker}, and 12 existing holders added to their shares. The total reported buy value for the quarter amounted to $15.2M.